Unilever’s men’s grooming brand, Axe, made history last year during Super Bowl XLVII after announcing plans to send one viewer to space as part of its Apollo campaign. This year, Axe returns to the big game to air a 30-second television commercial.
A panel of experts at the Food and Drug Administration has recommended approval for an experimental biotech drug under development by Bristol-Myers Squibb and AstraZeneca for a group of rare metabolic disorders.
Kaz announced the launch of the Braun Forehead Thermometer, which features a lightweight, ergonomic design, providing a step-by-step on-product usage guide and user-facing digital temperature readouts on a large, backlit screen.
The National Community Pharmacists Association urged U.S. Senators on the Senate Finance Committee to support a proposal intended to expand coverage in the Medicare Part D prescription drug program of medication therapy management programs.
Pharmacists have the ability to significantly increase vaccination rates in Canada and save the healthcare system money by reducing the number of hospitalizations due to complications from the flu, according to a new report developed by Shoppers Drug Mart.
GlaxoSmithKline announced that a peer-reviewed study issued online by the New England Journal of Medicine has reported that GSK’s FluLaval Quadrivalent reduced flu cases among children ages 3 years to 8 years by 55.4% overall and lowered the risk of developing moderate-to-serious flu illness by 73.1%.
While the Patient Protection and Affordable Care Act will undoubtedly reshape the U.S. healthcare industry for years to come, it is only one of many factors that will emerge next year, according to a new report.